two drugs that treat different indications but essentially have the same mechanism of action in humans.
- NYR targets calcium ion channels all over the body including the brain hence why it protects the heart in strokes and heart attacks
-AGN targets glutamate which stops production of calcium release in the brain
AGN has a chance to fail due to the target on glutamate is also important for survival of neurons in the brain hence why I sold out of AGN. NYR avoids this but AGN should get solid results because of NA-1
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.18M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.5¢ | 19.0¢ | $114.5K | 576.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 78460 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 60000 | 2 |
View Market Depth
| Last trade - 15.59pm 16/06/2025 (20 minute delay) ? |
| NYR (ASX) Chart |